Company / FCF Margin
Bristol Myers Squibb FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
26.7%
FY2025
5-year range
26.7% / 32.8%
FY2021-FY2025
Trend
-7.7%
vs FY2024
Sector context
#18 of 134
Health Care
What the data says
Bristol Myers Squibb's fcf margin of 26.7% is higher than 87% of companies in the Health Care sector (FY2025). FCF Margin has fluctuated over the past 10 years, ranging from 9.5% in FY2018 to 32.8% in FY2023.
Based on SEC 10-K filings.
26.7% in FY2025 with a 5-year CAGR of -4.6%. Top quartile in the Health Care sector.
Declined from 32.8% to 26.7% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -4.6pp
- 5-Year Change
- -4.6pp
- 10-Year Change
- -
Sector benchmark
Top 13% in Health CareTop 13% of 134This company 26.7% Sector average -637.8%
▼
+104.2% above sector average
Key checks
Key Insights
- In FY2025, fcf margin decreased 7.7% year-over-year.
- Currently 664.4pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2023.
- Lowest fcf margin in the period was in FY2018.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 26.7% | -7.7% |
| FY2024 | 28.9% | -12.1% |
| FY2023 | 32.8% | +5.0% |
| FY2022 | 31.3% | +10.9% |
| FY2021 | 28.2% | -9.8% |
| FY2020 | 31.3% | +54.0% |
| FY2019 | 20.3% | +114.0% |
| FY2018 | 9.5% | -53.3% |
| FY2017 | 20.3% | +23.0% |
| FY2016 | 16.5% | -10.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026